1Moses J W, Leon M B, Popma J J, et al. Sirolimus eluting stents versus standard stents in patients with stenoses in a native coronary artery[J]. N Eng J Med, 2003, 349: 1315.
2Smith S C, Dove J T, Kennedy J W, et aI. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines executive summary). A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (conmaittee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty)[J]. J Am Coll Cardiol, 2001, 37: 2215.
3Ruygrok P N, Muller D W, Serruys P W. Rapamycin in cardiovascular medicine[J]. Inter Med J, 2003, 33: 103.
2Serruys PW. ARTS I - the rapamycin eluting stent; ARTS II - the rosy prophecy. Eur Heart J, 2002, 23: 757-759.
3Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003, 349:1315-1323.
4Ruygrok PN, Muller DW, Serruys PW. Rapamycin in cardiovascular medicine. Intern Med J, 2003, 33:103-109.
5Lemos PA, Lee CH, Degertekin M, et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes. J Am Coll Cardiol, 2003, 41:2093-2099.
6Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation, 2004, 109: 1244-1249.
7Tanabe K, Hoye A, Lemos PA, el al. Restonosis rates following bifurcation stenting with sirolimus-eluting stents for De Novo narrowings. Am J Cardiol, 2004,91 : 115-118.
8Smith SC, Dove JT, Kennedy JW, et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PICA guidelines-executive summary). A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise, the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coil Cardiol, 2001,37:2215-2239.
9Ong AT, Aoki J, Mcfadden EP, et al. Classitication and current treatment options of in-stent restenoses. Present status and future perspectives. Herz, 2004,29: 187-194.
10Leon MB, T eirstein PS, Moses JW, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenoses after stenting. N Eng J Med, 2001,344:250-256.
